Target intelligence / Profile preview

DNA-topoisomerase I cleavage complex (Top1cc)

Target
Top1cc
Molecular classification
Enzyme-DNA complex, Type IB topoisomerase
01

Overview

The DNA-topoisomerase I cleavage complex (Top1cc) is a transient, covalent intermediate formed during the catalytic cycle of the enzyme topoisomerase I (Top1). Top1 is essential for relieving torsional strain in DNA by creating a single-strand nick, allowing the DNA to rotate and relax supercoils generated during replication and transcription [4, 11]. Under normal conditions, Top1 quickly religates the DNA and dissociates; however, certain conditions or drugs can trap the enzyme in this covalent state [4, 13]. In oncology, Top1cc is the primary target of "Top1 poisons" such as camptothecin and its derivatives, irinotecan and topotecan [1, 8]. These drugs act as interfacial inhibitors, binding at the junction of the enzyme and DNA to prevent religation [8, 9]. The resulting persistent Top1cc lesions lead to lethal double-strand breaks upon collision with replication or transcription forks, making them highly effective at inducing apoptosis in rapidly proliferating cancer cells [1, 13]. Beyond cancer, the inability to repair endogenous Top1cc is linked to neurodegenerative disorders like spinocerebellar ataxia with axonal neuropathy 1 (SCAN1) [4, 16].

Other names
Top1-DNA cleavage complexTopoisomerase I-DNA covalent complexTop1-DNA intermediateCleavable complexTop1cc
02

Mechanism of action

Interfacial inhibition by stabilizing the covalent DNA-enzyme complex and preventing DNA religation, leading to replication fork collision and double-strand breaks.

03

Biological functions

DNA replicationTranscriptionDNA relaxationGenome maintenance
04

Disease associations

CancerNeurodegenerative diseaseAutoimmune disease
05

Safety considerations

MyelosuppressionSevere diarrheaGastrointestinal toxicityNeurotoxicity in repair-deficient patients
06

Interacting drugs

Irinotecan

7 more in the full profile.

07

Biomarkers

SLFN11 expressionTopoisomerase I expressionTDP1 activityATM status

Beyond the preview

Go deeper on DNA-topoisomerase I cleavage complex (Top1cc).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA-topoisomerase I cleavage complex (Top1cc).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call